Hypertrophic cardiomyopathy (HCM) is the commonest inherited heart disease, characterised by ventricular hypertrophy that cannot be solely explained by increased afterload (e.g. arterial hypertension).

Sudden Cardiac Death is a devastating and often unpredictable complication of HCM; with 51% of all deaths being attributed due to arrhythmias such as ventricular tachycardia or ventricular fibrillation. The use of Implantable Cardioverter Defibrillators (ICDs) in this cohort has drastically reduced this risk amongst patients deemed at high arrhythmic risk. Whilst ICDs can save lives; shocks can strike twice, with a higher incidence of inappropriate shocks compared to traditional ICD patients, with a potential for long-term complications. How, therefore, should we manage these patients in the future?

There will be a live Q&A session after the talk with the speaker, Chris Monkhouse, Deputy Principal Cardiac Physiologist at Barts Heart Centre

ABOUT OUR SPEAKER

Clinical Lead for Devices & Deputy Principal Cardiac Scientist device (IBHRE accredited) at the Barts Heart Centre, London. Chris is a keen educator & researcher. He has presented at national and international conferences and published in multiple peer-reviewed academic journals, with dreams of completing a PhD in the future. With a passion for arrhythmia services. Chirs has a particular love for devices. Weird and wonderful cases will always excite! And don’t get him started on blanking...